Category: Cancer Treatment
Global Cancer Treatment
-
Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, Region - Global Forecast to 2028
... market size is projected to reach USD 19.8 billion by 2028 from USD 9.7 billion in 2023, at a CAGR of 15.2% during the forecast period. Factors such as the rising prevalence of cancer, robust ... Read More
-
Cancer Stem Cells Market Share, Size & Trends Analysis Report By Mode Of Action (Stem Cell based Cancer Therapy, Targeted CSCs), By Cancer Forms (Breast Cancer, Bladder Cancer), By Region, And Segment Forecasts, 2023 - 2030
... 2030 Cancer Stem Cells Market Growth & Trends The global cancer stem cells market size is expected to reach USD 3.1 billion by 2030, according to a new report by Grand View Research, Inc., expanding ... Read More
-
Global Interventional Pulmonology Market Size Study & Forecast, by Product (Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems), by Indication (Asthma, COPD, Lung Cancer, Tracheal and Bronchial Stenosis, Others), by End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others), and Regional Analysis, 2023-2030
... and Bronchial Stenosis, Others), by End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others), and Regional Analysis, 2023-2030 Global Interventional Pulmonology Market is valued at approximately USD 3.95 billion in 2022 and is anticipated ... Read More
-
Global Bispecific Antibodies Market Size Study & Forecast, by Indication (Cancer, Inflammatory & Autoimmune Disorders, Others), and Regional Analysis, 2023-2030
... anticipated to grow with a healthy growth rate of more than 44.0% over the forecast period 2023-2030. Bispecific antibodies are a class of therapeutic proteins created to attach to two distinct target molecules simultaneously. These ... Read More
-
Hairy Cell Leukemia Therapeutics Market by Product Type (Chemotherapy Drug, Immunotherapy Drug), Distribution Channel (Cancer Research Organization, Hospitals, Long Term Care Centers) - Global Forecast 2023-2030
... at USD 164.07 million in 2022 and expected to reach USD 177.88 million in 2023, at a CAGR 8.55% to reach USD 316.39 million by 2030. Market Segmentation & Coverage: This research report analyzes various ... Read More
-
Melanoma Drug Market by Type of Melanoma (Acral Lentiginous Melanoma, Lentigo Maligna Melanoma, Nodular Melanoma), Therapy (Chemotherapy, Immunotherapy, Targeted Therapy) - Global Forecast 2023-2030
... in 2022 and expected to reach USD 5.53 billion in 2023, at a CAGR 13.35% to reach USD 13.32 billion by 2030. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and ... Read More
-
Pharmacogenomics Technology Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Therapeutic Area (Oncology ( lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), Neurological Disorders, Cardiovascular Disease, Immunological Disorders, Infectious Diseases, Others), By Technology (PCR, In-situ Hybridization, Immunohistochemistry, Sequencing, Others), By Region, and Competition
... an impressive Compound Annual Growth Rate (CAGR) of 10.79% through 2028. This global market has experienced substantial expansion in recent years, primarily propelled by the rising awareness among consumers regarding the significance of gut health ... Read More
-
Global Non-Small Cell Lung Cancer Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Non-Small Cell Lung Cancer industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Non-Small Cell Lung Cancer. The report ... Read More
-
AI in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Others), By Region, By Competition
... in the forecasted period, with an anticipated Compound Annual Growth Rate (CAGR) of 11.38% through 2028. Biophotonics represents an interdisciplinary domain that amalgamates biology and photonics, which is the study of light, to foster pioneering ... Read More
-
Global Penile Cancer Treatment Market - 2023-2030
... during the forecast period 2023-2030. The penile cancer treatment market is driven by factors such as increasing incidence of penile cancer, advancements in treatment options, awareness, and early detection, supportive government initiatives, increasing healthcare expenditure, ... Read More
-
Global Retinoblastoma Market - 2023-2030
... The global retinoblastoma market experiencing significant growth in recent years. This type of eye cancer is most common in children younger than age 5, but in rare cases, it can develop in older children or ... Read More
-
2023-2027 World Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - A 92-Country Database and Analysis, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 92-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
Gastric Cancer Diagnostic Procedure Global Market Report 2023 Including: 1) By Procedure Type: Endoscopic Procedure; Biopsy; Tissue tests; Lab tests; In-vitro Diagnostic Tests; Imaging Tests; Molecular Diagnostics; Multiplexing Molecular Diagnostics; Immunoassays 2) By Symptom Type: Symptomatic; Asymptomatic 3) By Offering Type: Instruments; Reagents and Consumables; Services 4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue 5) By Disease Indication: Early Gastric Cancer; Advanced Gastric Cancer Covering: Pfizer Inc.; Johnson & Johnson Co; F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Bayer AG
... Asymptomatic3) By Offering Type: Instruments; Reagents and Consumables; Services4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue5) By Disease Indication: Early Gastric Cancer; Advanced Gastric CancerCovering: Pfizer Inc.; Johnson & Johnson Co; F. ... Read More
-
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids 3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons 4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B Covering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
... Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons4) ... Read More
-
Head And Neck Cancer Diagnostics Global Market Report 2023 Including: 1) By Diagnostic Method: Diagnostic Imaging Equipment; Endoscopy Screening Equipment; Biopsy Screening Tests; Dental Diagnostic Methods 2) By Channel: Retail and Specialty Pharmacies; Hospital Pharmacies; Online Pharmacies 3) By End-User: Hospitals; Diagnostic Centersrs Covering: F. Hoffmann-La Roche Ltd.; Bristol Myers Squibb Co.; Abbott Laboratories; Siemens Healthineers AG; BioNTech AG
... Pharmacies3) By End-User: Hospitals; Diagnostic CentersrsCovering: F. Hoffmann-La Roche Ltd.; Bristol Myers Squibb Co.; Abbott Laboratories; Siemens Healthineers AG; BioNTech AG Head And Neck Cancer Diagnostics Global Market Report 2023 from The Business Research Company ... Read More
-
G-Protein Coupled Receptors Global Market Report 2023 Including: 1) By Product: Cell Lines; Detection Kits; Cell Culture Reagents; Ligands 2) By Assay: CAMP Functional Assays; Calcium Functional Assays; β-Arrestin Functional Assays; Radioligand Binding and GTPγS Functional Assays; Internalization Assays; Trafficking Assays 3) By Applications: Cancer Research; CNS Research; Metabolic Research; Cardiovascular Research; Inflammation Research; Respiratory Research Covering: Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Bayer AG; Novartis International AG
... Assays; Internalization Assays; Trafficking Assays3) By Applications: Cancer Research; CNS Research; Metabolic Research; Cardiovascular Research; Inflammation Research; Respiratory ResearchCovering: Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Bayer AG; Novartis International AG G-Protein Coupled Receptors Global ... Read More
-
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023 Including: 1) By Drug Class: Nerve Protective Therapy; Anti-Inflammatory Therapy; Neurotransmitter Based Therapy; Antioxidantes 2) By Treatment: Medication; Therapy 3) By Drug Type: Branded; Generic 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies 5) By End-User: Hospitals; Research Institutes; Specialty Clinics Covering: Sanofi SA; Bristol Myers Squibb; Abbott Laboratories; Takeda Pharmaceutical Company; Amgen Inc.
... Hospital Pharmacy; Retail Pharmacy; Online Pharmacies5) By End-User: Hospitals; Research Institutes; Specialty ClinicsCovering: Sanofi SA; Bristol Myers Squibb; Abbott Laboratories; Takeda Pharmaceutical Company; Amgen Inc. Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023 from ... Read More
-
Ewing Sarcoma Drugs Market - Global Ewing Sarcoma Drugs Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Tumour Type Coverage, By Application Coverage Coverage, By End User Coverage, By Geographic Coverage and By Company)
... Coverage and By Company) Ewing Sarcoma Drugs Market Gains Momentum with Expected 5% CAGR, Surpassing $0.3 Billion by 2030 The global Ewing sarcoma drugs market is on a trajectory of significant growth, with a promising ... Read More
-
Cancer/Tumor Profiling Market by Biomarker Type (Genetic, Protein) Technology (NGS, PCR, ISH, IHC) Cancer Type (Breast, Lung, Colorectal, Prostate, Leukemia) Application (Clinical, Research) End User (Pharma, Academic, CRO) - Global Forecast to 2030
... market is projected to reach $22.3 billion by 2030, at a CAGR of 20.9% from 2023 to 2030. Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the ... Read More
-
Global Bone Cancer Treatment Market - 2023-2030
... the forecast period 2023-2030. Bone cancer is characterized by the uncontrolled growth of cells in the bone. Different types of bone tissue give rise to different types of primary bone cancer. Osteosarcoma develops from cells ... Read More
-
Global Cervical Cancer Diagnostics Market - 2023-2030
... the forecast period 2023-2030. Cervical cancers are caused by the virus HPV, a sexually transmitted infection. HPV spreads through sexual contact (anal, oral, or vaginal) and can lead to cancer. Cervical cancer can be detected ... Read More
-
Global Breast Cancer Diagnostics Market - 2023-2030
... the forecast period 2023-2030. According to the World Health Organization, breast cancer is the most commonly diagnosed type of cancer globally. The number of registered diagnostic breast cancer cases ase count has been estimated to ... Read More
-
Global Cancer Profiling Market Size study & Forecast, by Technology (Immunoassays, Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays, and Others), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), Biomarker Type (Genetic Biomarkers, Protein Biomarkers, and Others), and Regional Analysis, 2023-2030
... (Genetic Biomarkers, Protein Biomarkers, and Others), and Regional Analysis, 2023-2030 Global Cancer Profiling Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Sterile Injectable Contract Manufacturing Market - Global Sterile Injectable Contract Manufacturing Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 -(By Molecule Type Coverage, By Therapeutic Application Coverage, By Route of administration Coverage, By Geographic Coverage and Leading Companies)
... By Geographic Coverage and Leading Companies) Global Sterile Injectable Contract Manufacturing Market Poised for Exceptional Growth, Projected to Reach US$30 Billion by 2030 The global sterile injectable contract manufacturing market is on the verge of ... Read More
-
Global Hepatoblastoma Market - 2023-2030
... The trend such as shift towards personalized medicine by better understanding of specific genetic makeup is expected to dominate the global hepatoblastoma market. The global hepatoblastoma market has grown significantly in recent years and is ... Read More
Research Assistance
